- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 14 Nov 2024
- latest of these filings; the earliest 9 Aug 2024
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 17 listed it in both
- Shares listed
- 39,053,712
- combined, among listed positions
- Reported value
- $4.3bn
- combined, at the quarter end
Among the 94 comparable managers: 15 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing EMR in Q2 2024
24 of 24 holders
Largest increases and reductions, by shares
Increases
- Invesco Ltdexisting position · 11,574,648 shares now+806,429
- Renaissance Technologies LLCnew position · 556,500 shares now+556,500
- Wellington Management Group LLPexisting position · 13,971,442 shares now+345,050
- Moore Capital Management LPexisting position · 287,761 shares now+254,854
- Schonfeld Strategic Advisors LLCexisting position · 232,566 shares now+117,238
Reductions
- Holocene Advisors LPexisting position · 51,888 shares now-939,881
- Citadel Advisors LLCexisting position · 1,354,871 shares now-729,651
- Two Sigma Advisers LPexisting position · 291,100 shares now-401,197
- AllianceBernstein LPexisting position · 1,131,125 shares now-255,334
- Man Group PLCexisting position · 243,200 shares now-123,538
New positions and exits
New (2)
Exited (1)
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 14 | $2.6bn | n.a. | n.a. |
| Q3 2013 | 13 | $3.5bn | n.a. | n.a. |
| Q4 2013 | 16 | $3.8bn | n.a. | n.a. |
| Q1 2014 | 18 | $3.2bn | n.a. | n.a. |
| Q2 2014 | 22 | $3.1bn | n.a. | n.a. |
| Q3 2014 | 18 | $2.7bn | n.a. | n.a. |
| Q4 2014 | 17 | $2.2bn | n.a. | n.a. |
| Q1 2015 | 17 | $2.0bn | n.a. | n.a. |
| Q2 2015 | 20 | $2.5bn | n.a. | n.a. |
| Q3 2015 | 18 | $2.3bn | n.a. | n.a. |
| Q4 2015 | 16 | $2.3bn | n.a. | n.a. |
| Q1 2016 | 16 | $2.7bn | n.a. | n.a. |
| Q2 2016 | 13 | $2.7bn | n.a. | n.a. |
| Q3 2016 | 17 | $3.2bn | n.a. | n.a. |
| Q4 2016 | 16 | $3.0bn | n.a. | n.a. |
| Q1 2017 | 17 | $2.4bn | n.a. | n.a. |
| Q2 2017 | 14 | $2.3bn | n.a. | n.a. |
| Q3 2017 | 14 | $2.4bn | n.a. | n.a. |
| Q4 2017 | 18 | $2.9bn | n.a. | n.a. |
| Q1 2018 | 17 | $2.6bn | n.a. | n.a. |
| Q2 2018 | 17 | $2.6bn | n.a. | n.a. |
| Q3 2018 | 16 | $2.9bn | n.a. | n.a. |
| Q4 2018 | 20 | $2.9bn | n.a. | n.a. |
| Q1 2019 | 20 | $2.6bn | n.a. | n.a. |
| Q2 2019 | 15 | $2.5bn | n.a. | n.a. |
| Q3 2019 | 16 | $2.2bn | n.a. | n.a. |
| Q4 2019 | 23 | $3.4bn | n.a. | n.a. |
| Q1 2020 | 17 | $2.0bn | n.a. | n.a. |
| Q2 2020 | 16 | $2.4bn | n.a. | n.a. |
| Q3 2020 | 18 | $2.4bn | n.a. | n.a. |
| Q4 2020 | 18 | $3.5bn | n.a. | n.a. |
| Q1 2021 | 16 | $3.8bn | n.a. | n.a. |
| Q2 2021 | 20 | $4.6bn | n.a. | n.a. |
| Q3 2021 | 17 | $4.4bn | n.a. | n.a. |
| Q4 2021 | 20 | $3.7bn | n.a. | n.a. |
| Q1 2022 | 21 | $3.3bn | n.a. | n.a. |
| Q2 2022 | 24 | $2.8bn | n.a. | n.a. |
| Q3 2022 | 28 | $3.1bn | n.a. | n.a. |
| Q4 2022 | 21 | $4.3bn | n.a. | n.a. |
| Q1 2023 | 26 | $4.3bn | n.a. | n.a. |
| Q2 2023 | 24 | $4.1bn | n.a. | n.a. |
| Q3 2023 | 20 | $3.8bn | n.a. | n.a. |
| Q4 2023 | 18 | $3.5bn | 10 | 8 |
| Q1 2024 | 19 | $4.1bn | 11 | 8 |
| Q2 2024 | 24 | $4.3bn | 15 | 8 |
| Q3 2024 | 14 | $3.8bn | 7 | 6 |
| Q4 2024 | 10 | $4.1bn | 4 | 9 |
| Q1 2025 | 11 | $4.0bn | 9 | 2 |
| Q2 2025 | 16 | $5.4bn | 12 | 4 |
| Q3 2025 | 13 | $4.7bn | 6 | 8 |
| Q4 2025 | 14 | $4.5bn | 16 | 16 |
| Q1 2026 | 16 | $4.6bn | 16 | 15 |
| Q2 2026 | 14 | $4.7bn | 14 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
EMR and GE →EMR and LRCX →EMR and GEV →Choose a stock to compare with EMR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own EMR, latest filings →Back to the 13F Explorer →